
CAS 65807-02-5: Goserelin
Formula:C59H84N18O14
InChI:InChI=1/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1
Synonyms:- 5-oxoprolylhistidyl-N-[18,18-diamino-7-(tert-butoxymethyl)-13-({2-[(2-carbamoylhydrazinyl)carbonyl]pyrrolidin-1-yl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-(2-methylpropyl)-2,5,8,11-tetraoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]tryptophanamide
- 5-oxo-L-prolyl-L-histidyl-N-[(1S,4S,7R,10S,13S)-18,18-diamino-7-(tert-butoxymethyl)-13-({(2S)-2-[(2-carbamoylhydrazino)carbonyl]pyrrolidin-1-yl}carbonyl)-4-(4-hydroxybenzyl)-1-(hydroxymethyl)-10-(2-methylpropyl)-2,5,8,11-tetraoxo-3,6,9,12,17-pentaazaoctadec-17-en-1-yl]-L-tryptophanamide
- 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide
- Decapeptide I
- Ici 118630
- Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-10-deglycinamide-, 2-(aminocarbonyl)hydrazide
- Zoladex
Sort by
Found 11 products.
Goserelin validation mixture CRS
CAS:Goserelin validation mixture CRSFormula:C59H84N18O14Molecular weight:1269.411Goserelin for NMR identification CRS
CAS:Goserelin for NMR identification CRSFormula:C59H84N18O14Molecular weight:1269.411Goserelin
CAS:Goserelin is a hormone that is used to treat certain types of breast cancer in women who are premenopausal. It has been shown that Goserelin can be used for the treatment of endometriosis and radiation therapy for cancer. Goserelin is also used to prevent recurrence of prostate cancer in men who have had surgery or radiation therapy. Goserelin is also used as an anticancer agent for the treatment of platinum-resistant ovarian cancer in women who are premenopausal and cannot be treated with other agents. The mechanism by which it works is not fully understood, but it has been shown to inhibit the growth of tumor cells in vitro and in vivo.Formula:C59H84N18O14Purity:Min. 95%Molecular weight:1,269.41 g/molGoserelin-d7 Tritrifluoroacetate
CAS:Formula:C59H77D7N18O14·3C2HF3O2Color and Shape:White To Off-White SolidMolecular weight:1276.48 3*114.02Goserelin Acetate
CAS:Formula:C59H84N18O14Purity:95%~99%Color and Shape:White to Off-white PowderMolecular weight:1269.42(D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base)
CAS:Bachem ID: 4073798.Formula:C59H84N18O14Purity:98.7%Color and Shape:White LyophilisateMolecular weight:1269.43